L-732138
CAS No. 148451-96-1
L-732138 ( —— )
Catalog No. M21568 CAS No. 148451-96-1
L-732138 is a potent and competitive antagonist of neurokinin-1 (NK-1) receptor(IC50 : 2.3 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 40 | Get Quote |
|
5MG | 65 | Get Quote |
|
10MG | 110 | Get Quote |
|
25MG | 205 | Get Quote |
|
50MG | 357 | Get Quote |
|
100MG | 530 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameL-732138
-
NoteResearch use only not for human use.
-
Brief DescriptionL-732138 is a potent and competitive antagonist of neurokinin-1 (NK-1) receptor(IC50 : 2.3 nM).
-
DescriptionL-732138 is a potent and competitive antagonist of neurokinin-1 (NK-1) receptor(IC50 : 2.3 nM).
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetNeurokinin Receptor
-
RecptorNK-1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number148451-96-1
-
Formula Weight472.38
-
Molecular FormulaC22H18F6N2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)OCc1cc(cc(c1)C(F)(F)F)C(F)(F)F
-
Chemical Name[35-Bis(trifluoromethyl)phenyl]methyl (2S)-2-acetamido-3-(1H-indol-3-yl)propanoate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mu?oz M et al. The NK-1 Receptor Antagonist L-732138 Induces Apoptosis and Counteracts Substance P-Related Mitogenesis in Human Melanoma Cell Lines. Cancers (Basel). 2010 Apr 20;2(2):611-23.
molnova catalog
related products
-
MLE-4901
A potent, selective, orally active neurokinin 3 (NK3R) antagonist for the treatment of schizophrenia.
-
Neurokinin A
Neurokinin A (NKA), formerly known as Substance K, is a neurologically active peptide translated from the pre-protachykinin gene. Neurokinin A (substance K) is a peptide neurotransmitter of the tachykinin family with potential as a major mediator in human airway and gastrointestinal tissues.
-
Fezolinetant
A potent, selective, orally active neurokinin-3 receptor (NK3R) antagonist with pIC50/pKi of 7.7/7.6.